Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma
Abstract Background Guidelines recommend thromboprophylaxis for patients with multiple myeloma (MM) at high risk for venous thromboembolism (VTE). However, the optimal risk prediction model for VTE in MM remains unclear. Khorana et al developed a VTE risk score (Khorana score) in ambulatory cancer p...
Main Authors: | Kristen M. Sanfilippo, Kenneth R. Carson, Tzu‐Fei Wang, Suhong Luo, Natasha Edwin, Nicole Kuderer, Jesse M. Keller, Brian F. Gage |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12634 |
Similar Items
-
Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
by: Fumie Akasaka-Kihara, MD, et al.
Published: (2021-09-01) -
Venous thromboembolism in multiple myeloma is associated with increased mortality
by: Martin W. Schoen, et al.
Published: (2020-10-01) -
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
by: Rachael N. Piver, et al.
Published: (2023-04-01) -
Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients
by: Ruyao Wang, et al. -
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
by: Hyerim Ha, et al.
Published: (2023-06-01)